Breaking News Instant updates and real-time market news.

BIOS

BioScrip

$3.25

0.05 (1.56%)

07:39
10/11/16
10/11
07:39
10/11/16
07:39

BioScrip file to sell 3.75M shares for selling stockholders

  • 15

    Nov

BIOS BioScrip
$3.25

0.05 (1.56%)

03/04/16
SPHN
03/04/16
NO CHANGE
Target $3.25
SPHN
Overweight
BioScrip balance sheet improved from 'terrifying' to just 'scary,' says Stephens
Stephens analyst Dana Hambly said he is starting to regain confidence in the leadership of BioScrip after the company's second straight quarter of above consensus results. The company's balance sheet is "still scary" due to the company's leverage, but that is an improvement from its prior "terrifying" level, Hambly tells investors. The company has a "real opportunity" for double-digit profitability growth, said the analyst, who keeps an Overweight rating and $3.25 price target on BioScrip shares.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.